The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Annual Contributions

Annual membership fees vary according to a company’s size, as outlined below:

 Size of company Start-up / small business Medium-sized enterprise Large healthcare company*
Criteria No oncology product on the market and revenues ≤ € 50 million Either low revenues and at least one oncology product on the market or medium to large revenues and no oncology product on the market At least one oncology product on the market and revenues ≥ € 1 billion
2024 Membership fee € 7 700** € 19 800** € 44 000**

* Is considered Healthcare Company any company or commercial institution, or any division or subsidiary of any company or commercial institution, that is principally engaged in the health care industry, which shall include any types of health care business such as pharmaceutical companies; medical supply and equipment companies; technology, software, communications, financing and services vendors selling predominantly to health care companies; companies providing health insurance; clinical research organization and managed care companies. 

**The membership fee is subject to an annual adjustment in line with the Belgian inflation rate for the previous year. Members are notified of fee inflation in September. 

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70